Multivalvular Disease: Percutaneous Management in 2019 and Beyond

Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patien...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Magdalena Erlebach, Rüdiger Lange
Formato: article
Lenguaje:EN
Publicado: Radcliffe Medical Media 2019
Materias:
Acceso en línea:https://doaj.org/article/81d87deb3f12433da9dfc3a9365d8cfa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:81d87deb3f12433da9dfc3a9365d8cfa
record_format dspace
spelling oai:doaj.org-article:81d87deb3f12433da9dfc3a9365d8cfa2021-12-04T16:02:04ZMultivalvular Disease: Percutaneous Management in 2019 and Beyond10.15420/icr.2019.13.R11756-14851756-1477https://doaj.org/article/81d87deb3f12433da9dfc3a9365d8cfa2019-11-01T00:00:00Zhttps://www.icrjournal.com/articles/Multivalvular-Disease-Percutaneous-Management-2019https://doaj.org/toc/1756-1477https://doaj.org/toc/1756-1485Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population.Magdalena ErlebachRüdiger LangeRadcliffe Medical MediaarticleSurgeryRD1-811Diseases of the circulatory (Cardiovascular) systemRC666-701ENInterventional Cardiology: Reviews, Research, Resources, Vol 14, Iss 3, Pp 142-146 (2019)
institution DOAJ
collection DOAJ
language EN
topic Surgery
RD1-811
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Surgery
RD1-811
Diseases of the circulatory (Cardiovascular) system
RC666-701
Magdalena Erlebach
Rüdiger Lange
Multivalvular Disease: Percutaneous Management in 2019 and Beyond
description Patients with multivalvular disease (MVD) are common and often present with heterogeneous valve defects. Evaluation is complicated by interactions among various valve pathologies. Trials and guidelines focus primarily on single-valve disease, providing few recommendations for the treatment of patients with MVD. This article provides an insight into percutaneous treatment possibilities for this heterogeneous patient population.
format article
author Magdalena Erlebach
Rüdiger Lange
author_facet Magdalena Erlebach
Rüdiger Lange
author_sort Magdalena Erlebach
title Multivalvular Disease: Percutaneous Management in 2019 and Beyond
title_short Multivalvular Disease: Percutaneous Management in 2019 and Beyond
title_full Multivalvular Disease: Percutaneous Management in 2019 and Beyond
title_fullStr Multivalvular Disease: Percutaneous Management in 2019 and Beyond
title_full_unstemmed Multivalvular Disease: Percutaneous Management in 2019 and Beyond
title_sort multivalvular disease: percutaneous management in 2019 and beyond
publisher Radcliffe Medical Media
publishDate 2019
url https://doaj.org/article/81d87deb3f12433da9dfc3a9365d8cfa
work_keys_str_mv AT magdalenaerlebach multivalvulardiseasepercutaneousmanagementin2019andbeyond
AT rudigerlange multivalvulardiseasepercutaneousmanagementin2019andbeyond
_version_ 1718372745916448768